The Office of Research Regulatory Affairs (ORRA) acts on behalf of UAMS to fulfill sponsor responsibilities on investigator-initiated studies that require Investigational New Drug Applications (INDs) and Investigational Device Exemptions (IDEs). For these studies, ORRA can assist with all stages, including regulatory analysis, planning, start-up activities, management and close-out.
ORRA is a diverse team of experienced professionals who serve the UAMS research community by providing assistance with:
- Regulatory Submissions
- Clinical Trial Monitoring
- ClinicalTrials.gov Registration and Maintenance
- Good Tissue Practice
We pride ourselves on understanding and anticipating the needs of the research community while providing essential support to enable the development of well-designed, ethical studies that balance regulation with innovation in a continuously changing environment.
We provide relevant education to the research community in an effort to create an environment in which best practices become standard practices.
We are committed to quality, responsiveness and cooperation in all of our endeavors.
We treat everyone with honesty, fairness, dignity, and respect.
We believe in open communication and constructive feedback.
We act with integrity and follow the highest ethical standards in all that we do.
We constantly strive to contribute to the image of UAMS as a premier research organization at the local, national and international levels.
WE STRIVE TO CONSTANTLY IMPROVE AND INNOVATE!
Please contact us if you believe we can be of assistance to you.